Navigation Links
In Some Insomnia Patients, Brain Just Won't Shut Down
Date:6/9/2009

Abnormal levels of a neurochemical are linked to sleep disorder, study finds

TUESDAY, June 9 (HealthDay News) -- Adults with primary insomnia have a neurochemical abnormality that makes it difficult to "shut down" the mind at night for sleep, new research has found.

Researchers measured the levels of gamma-aminobutyric acid (GABA) in 16 adult men and women with primary insomnia and 16 men and women deemed normal sleepers.

Primary insomnia is difficulty falling sleep or staying asleep at night for over a period of at least one month, according to the American Academy of Sleep Medicine. Unlike most cases of insomnia, primary insomnia can't be attributed to a psychiatric, medical or environmental cause.

The new study found that people who had suffered from primary insomnia for more than six months had 30 percent lower levels of GABA.

GABA, the most common inhibitory transmitter in the brain, slows overall activity in many brain areas.

The research was to be presented June 9 at the annual meeting of the Associated Professional Sleep Societies, in Seattle.

The findings suggest that primary insomnia is the result of a neurobiological state of hyperarousal, and that this state remains throughout the day and night, affecting the individual's mind and body, according to a news release from the American Academy of Sleep Medicine. About one-quarter of people with insomnia have this type, the Academy stated.

Understanding that primary insomnia is associated with a specific neurochemical deficiency helps validate the often-misunderstood complaint of insomnia, explained lead study author Dr. John Winkelman of Brigham and Women's Hospital at Harvard Medical School in Boston.

"Recognition that insomnia has manifestations in the brain may increase the legitimacy of those who have insomnia and report substantial daytime consequences," Winkelman said. "Insomnia is not just a phenomenon observed at night, but has daytime consequences for energy, concentration and mood."

More information

The U.S. National Institutes of Health has more on primary insomnia.



-- Jennifer Thomas



SOURCE: American Academy of Sleep Medicine, news release, June 9, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Link Between Chronic Pain and Insomnia Uncovered at PAINWeek 2007
2. Evotec Reports Positive Top-Line Results in Phase II Study With EVT 201 in Elderly Insomniacs With Daytime Sleepiness
3. Insomniac Fish May Help Sleepless People
4. Journal Sleep: A short-term dose of zolpidem is an effective treatment for insomnia
5. Ambien CR(R) (zolpidem tartrate extended-release) tablets CIV Improved Chronic Insomnia in Patients with Co-Morbid Generalized Anxiety Disorder
6. Insomnia patients often denied sleep treatment when they have mental health conditions
7. Adolescents with chronic insomnia report twofold to fivefold increase in personal problems
8. Persistent Insomnia Leads to Depression in Young Adults
9. An Eye-Opening Look at Insomnia
10. A self-help program delivered online can improve insomnia in adults
11. Insomnia in parents can result in sleep problems, suicidal behavior among their offspring
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
In Some Insomnia Patients, Brain Just Won't Shut Down
(Date:12/8/2016)... ... December 08, 2016 , ... ZyDoc , ... Processing–Enabled and Conventional Data Capture Methods for Input to Electronic Health Records: A ... Results of the comparative usability study demonstrate that a dictation-based method (“NLP Entry”) ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... David ... with global law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, ... of the DeviceTalks series, and attorneys from the firm’s global Life Sciences & Medical ...
(Date:12/8/2016)... ... December 08, 2016 , ... STATEN ISLAND, ... recognized for adherence to the highest standards of trauma, maternity, cancer and chronic ... center's president and CEO, Dr. Daniel Messina. , Among the recognitions, the American ...
(Date:12/8/2016)... ... ... Vida Health, the digital health platform that pairs individuals with ... . Other investors include Nokia Growth Partners (NGP) and returning investor Aspect Ventures. Vida ... are managing chronic conditions or simply want to improve their health. Canvas ...
(Date:12/8/2016)... ... ... Coppin Insurance Agency, an insurance and financial planning firm based in Lee ... is embarking on a charity drive with the goal of providing support and donations ... Bank of Southwest Florida works to provide fresh and nutritious food free of charge ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  Eli Lilly and Company ... of its phase 3 EXPEDITION3 trial at the 9 ... As previously disclosed, solanezumab did not meet the primary ... solanezumab initiated in people with mild dementia due to ... submissions for solanezumab for the treatment of mild dementia ...
(Date:12/8/2016)... QUEBEC CITY , Dec. 8, 2016 /PRNewswire/ ... key US patents for improving the accuracy, reproducibility ... CD images in long and small bone orthopaedic ... proprietary approach to creating personalized orthopaedic restorations based ... create personalized orthopaedic restorations, the company harnesses the ...
(Date:12/8/2016)... Dec. 8, 2016  EIP Pharma, LLC ( ... proof-of-mechanism for neflamapimod (previously code named VX-745), with ... clinical trials that demonstrated significant Alzheimer,s disease relevant ... treatment) and Study 303 (6-week treatment) are the ... Alzheimer,s Disease (CTAD) scientific conference in ...
Breaking Medicine Technology: